Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 376,976 | 394,953 | 382,114 | 0 | N/A |
| TOTAL | $381,736 | $401,229 | $384,752 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 6,507 | 5,834 | 2,343 | N/A | N/A |
| Other Non-Current Assets | 13,744 | 9,089 | 11 | 0 | 0 |
| TOTAL | $20,251 | $14,923 | $2,354 | $N/A | $N/A |
| Total Assets | $401,987 | $416,152 | $387,106 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,453 | 1,763 | 4,046 | 0 | 0 |
| Accrued Expenses | 4,208 | 4,703 | 3,812 | 0 | N/A |
| TOTAL | $12,143 | $11,272 | $7,858 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,794 | 4,748 | 64 | 0 | 0 |
| TOTAL | $5,794 | $4,748 | $64 | $N/A | $N/A |
| Total Liabilities | $17,937 | $16,020 | $7,922 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,290 | 8,299 | 8,299 | N/A | N/A |
| Common Shares | 1 | 1 | 1 | 0 | N/A |
| Retained earnings | -141,351 | -122,421 | -107,829 | 0 | N/A |
| TOTAL | $384,050 | $400,132 | $379,184 | $0 | $N/A |
| Total Liabilities And Equity | $401,987 | $416,152 | $387,106 | $0 | $0 |